Resistin worsens cardiac ischaemia-reperfusion injury

Biochemical and Biophysical Research Communications

Volumn 349, Issue 1, 2006, Pages 400-407

  Rothwell, Sarah E ^a   Richards, A Mark ^a   Pemberton, Christopher J ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Ischaemia; Isolated heart; NF B; Resistin; TNF

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE; RECOMBINANT PROTEIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; CYTOKINE RELEASE; GLUCOSE TRANSPORT; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEMODYNAMICS; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALS; CREATINE KINASE; ENZYME INHIBITORS; GLUCOSE; HUMANS; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NITRILES; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; RESISTIN; SULFONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33748297588     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.08.052     Document Type: Article

References (39)

1. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., Hiralben R.P., Ahima R.S., and Lazar M.A. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
2. Patel L., Buckels A.C., Kinghorn I.J., Murdock P.R., Holbrook J.D., Plumpton C., Macphee C.H., and Smith S.A. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem. Biophy. Res. Comm. 300 (2003) 472-476
3. Banerjee R.R., and Lazar M.A. Resistin: molecular history and prognosis. J. Mol. Med. 81 (2003) 218-226
4. Schinke T., Haberland M., Jamshidi A., Nollau P., Rueger J.M., and Amling M. Cloning and functional characterization of resistin-like molecule [gamma]. Biochem. Biophy. Res. Comm. 314 (2004) 356-362
5. Banerjee R.R., Rangwala S.M., Shapiro J.S., Rich A.S., Rhoades B., Qi Y., Wang J., Rajala M.W., Pocai A., Scherer P.E., Steppan C.M., Ahima R.S., Obici S., Rossetti L., and Lazar M.A. Regulation of fasted blood glucose by resistin. Science 303 (2004) 1195-1198
6. Rangwala S.M., Rich A.S., Rhoades B., Shapiro J.S., Obici S., Rossetti L., and Lazar M.A. Abnormal Glucose Homeostasis due to Chronic Hyperresistinemia. Diabetes 53 (2004) 1937-1941
7. Degawa-Yamauchi M., Bovenkerk J.E., Juliar B.E., Watson W., Kerr K., Jones R., Zhu Q., and Considine R.V. Serum Resistin (FIZZ3) Protein is increased in Obese Humans. J. Clin. Endocrinol. Metab. 88 (2003) 5452-5455
8. Kim K.-H., Zhao L., Moon Y., Kang C., and Sul H.S. Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity. PNAS 101 (2004) 6780-6785
9. Blagoev B., Kratchmarova I., Nielsen M.M., Fernandez M.M., Voldby J., Andersen J.S., Kristiansen K., Pandey A., and Mann M. Inhibition of adipocyte differentiation by Resistin-Like molecule αbiochemical characterization of its oligomeric nature. J. Biol. Chem. 277 (2002) 42011-42016
10. Caja S., Martinez I., Abelenda M., and Puerta M. Resistin expression and plasma concentration peak at different times during pregnancy in rats. J. Endocrinol. 185 (2005) 551-559
11. Yura S., Sagawa N., Itoh H., Kakui K., Nuamah M.A., Korita D., Takemura M., and Fujii S. Resistin Is Expressed in the Human Placenta. J. Clin. Endocrinol. Metab. 88 (2003) 1394-1397
12. Pittas A.G., Joseph N.A., and Greenberg A.S. Adipocytokines and Insulin Resistance. J. Clin. Endocrinol. Metab. 89 (2004) 447-452
13. Kawanami D., Maemura K., Takeda N., Harada T., Nojiri T., Imai Y., Manabe I., Utsunomiya K., and Nagai R. Direct reciprocal effects of resistin and adiponecin on vascular endothelial cells: a new insight into adipocytokine-endothelial interactions. Biochem. Biophy. Res. Comm. 314 (2003) 415-419
14. Jung H.S., Park K.-H., Cho Y.M., Chung S.S., Cho H.J., Cho S.Y., Kim S.J., Kim S.Y., Lee H.K., and Park K.S. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc. Res. 69 (2005) 76-85
15. Kresk M., Silha J.V., Jezkova J., Hana V., Marek J., Weiss V., Steppan J.J., and Murphy L.J. Adipokine levels in Cushing's syndrome; elevated resistin levels in female patients with Cushing's syndrome. Clin. Endocrinol. 60 (2004) 350-357
16. Lee J.H., Chan J., Yiannakouris L.N., Kontogianni M., Estrada E., Seip R., Orlova C., and Mantzoroz C.S. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: Cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J. Clin. Endocrinol. Metab. 88 (2003) 4848-4856
17. Verma S., Li S.-H., Wang C.-H., Fedak P.W.M., Li R.-K., Weisel R.D., and Mickle D.A.G. Resistin promotes Endothelial Cell Activation Further evidence of Adiopokine-Endothelial Interaction. Circulation 108 (2003) r24-r28
18. Bokarewa M., Nagaev I., Dahlberg L., Smith U., and Tarkowski A. Resistin, an Adipokine with Potent Proinflammatory Properties. J. Immunol. 174 (2005) 5789-5795
19. Al-Daghri N., Chetty R., McTernan P.G., Al-Rubean K., Al-Attas O., Jones A.F., and Kumar S. Serum resistin is associated with C-reactive protein and LDL- cholesterol in type 2 diabetes and coronary artery disease in a Saudi population. Cardiovasc. Diabetol. 4 (2005) 10
20. Reilly M.P., Lehrke M., Wolfe M.L., Rohatgi A., Lazar M.A., and Rader D.J. Resistin Is an Inflammatory Marker of Atherosclerosis in Humans. Circulation 111 (2005) 932-939
21. Pemberton C.J., Raudsepp S.D., Yandle T.G., Cameron V.A., and Richards A.M. Plasma cardiotrophin-1 is elevated in human hypertension and stimulated by ventricular stretch. Cardiovasc. Res. 68 (2005) 109-117
22. Pemberton C.J., Johnson M.L., Yandle T.G., and Espiner E.A. Deconvolution Analysis of Cardiac Natriuretic Peptides During Acute Volume Overload. Hypertension 36 (2000) 355-359
23. Silswal N., Singh A.K., Aruna B., Mukhopadhyay S., Ghosh S., and Ehtesham N.Z. Human resistin stimulatesthe pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kB-dependent pathway. Biochem. Biophy. Res. Comm. 334 (2005) 1092-1101
24. D'Souza S.P., Davis M., and Baxter G.F. Autocrine and paracrine actions of natriuretic peptides in the heart. Pharmacol. Ther. 101 (2004) 113-129
25. Yokoyama T., Vaca L., Rossen R., Durante W., Hazarika P., and Mann D. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J. Clin. Invest. 92 (1993) 2303-2312
26. Murphy H., Shayman J., Till G., Mahrougui M., Owens C., Ryan U., and Ward P. Superoxide responses of endothelial cells to C5a and TNF-alpha: divergent signal transduction pathways. Am. J. Physiol. Lung Cell. Mol. Physiol. 263 (1992) L51-L59
27. Li D., Zhao L., Liu M., Du X., Ding W., Zhang J., and Mehta J.L. Kinetics of tumor necrosis factor alpha in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor alpha in acute myocardial infarction. Am. Heart J. 137 (1999) 1145-1152
28. Gurevitch J., Frolkis Md I., Yuhas Y., Lifschitz-Mercer B., Berger E., Paz Y., Matsa M., Kramer A., and Mohr R. Anti-Tumor Necrosis Factor-Alpha Improves Myocardial Recovery After Ischemia and Reperfusion. J. Am. Coll. Cardiol. 30 (1997) 1554-1561
29. Baldwin Jr. A.S. The transcription factor NF-{{kappa}}B and human disease. J. Clin. Invest. 107 (2001) 3-6
30. Klemm P., Warner T.D., Hohlfeld T., Corder R., and Vane J.R. Endothelin 1 Mediates ex vivo Coronary Vasoconstriction Caused by Exogenous and Endogenous Cytokines. PNAS 92 (1995) 2691-2695
31. Yang T.-L., Chen M.-F., Jiang J.-L., Xie Q.-Y., Li Y.-P., and Li Y.-J. The endothelin receptor antagonist decreases ischemia/reperfusion-induced tumor necrosis factor production in isolated rat hearts. Int. J. Cardiol. 100 (2005) 495-498
32. Zhang J.L., Quin Y.W., Zheng X., Qui J.L., and Zou D.J. Serum resistin level in essential hypertension patients with different glucose tolerance. Diabet. Med. 20 (2003) 828-831
33. Youn B.-S., Yu K.-Y., Park H.J., Lee N.S., Min S.S., Youn M.Y., Cho Y.M., Park Y.J., Kim S.Y., Lee H.K., and Park K.S. Plasma resistin concentrations measured by enzyme linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 89 (2004) 150-156
34. McTernan P.G., Folliott M.F., Valsamakis G., Rajkumar C., Harte A., McTernan C.L., Clarke P.M.S., Smith S.A., Barnett A.H., and Kumar S. Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid glucose metabolism in human differentiated adipocytes. J. Clin. Endocrinol. Metab. 88 (2003) 6098-6106
35. Satoh H., Nguyen M.T.A., Miles P.D.G., Imamura T., Usui I., and Olefsky J.M. Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. J. Clin. Invest. 114 (2004) 224-231
36. Bajaj M., Suraamornkull S., Hardies L., Pratipanawatr T., and DeFronzo R. Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients. Int. J. Obes. 28 (2004) 783-789
37. Lee J.H., Bullen Jr. J.W., Stoyneva V.L., and Mantzoros C.S. Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E625-E632
38. Stejskal A.S.D., Bartek J., Jurakova R., and Proskova J. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech. Repub. 147 (2003) 63-69
39. Fehmann H., and Heyn J. Plasma Resistin Levels in Patients with Type 1 and Type 2 Diabetes Mellitus and in Healthy Controls. Horm. Metab. Res. 34 (2002) 671-673